Thyroid disorder decisions — 2024

The Board has granted service connection for thyroid cancer and Crohn's disease, finding that both conditions are more likely than not caused by the Veteran's exposure to Agent Orange during his military service.

The Board has determined that the Veteran's claims for an earlier effective date and increased rating for hypothyroidism are remanded due to insufficient evidence in the April 2022 VA examination.

The Veteran's service-connected hypothyroidism is currently rated at 60 percent, effective January 28, 2005.,From January 28, 2005 to May 3, 2019, the Veteran was granted TDIU based on his service-connected hypothyroidism.

The Veteran's appeal has been dismissed due to their passing away during the pendency of this appeal.

The Board has decided to remand the case due to a duty-to-assist error, requiring an updated VA examination and rating determination for the Veteran's service-connected hypothyroidism.

The Board has denied service connection for a right ankle condition, reoccurring migraines, hypothyroidism, and hypertension. The claims are being remanded due to insufficient evidence.

The Veteran's claim for a compensable rating for his service-connected hypothyroidism was dismissed as the appeal is improper and does not constitute a valid appeal of the February 2023 rating decision.

The Board has remanded the claims of hypertension, hypothyroidism, and parkinsonism due to potential exposure to toxins during service. A VA examination is needed for each condition.

The Board denied service connection for multiple disorders, including right and left hip, right knee, right shoulder, left hand (finger), left elbow, vision impairment, thyroid cancer, psychiatric disorder (to include depression and anxiety), separate psychiatric disorder, neck muscle spasms, left shoulder muscle spasms, and a left knee sprain.

The Veteran's claim for service connection for thyroid cancer is being remanded due to the submission of new and relevant evidence since the August 2020 rating decision.

The Board has remanded the Veteran's claims of service connection for left and right knee DJD, as well as her claim for hypothyroidism due to lack of sufficient evidence at the time of the initial rating decisions.

The Veteran's service connection claims for various disabilities are being remanded due to the need to obtain her Reserve service records and provide TERA opinions regarding certain conditions.

The Board has decided to remand the case due to a pre-decisional duty to assist error, specifically regarding the adequacy of the February 2024 VA examination. The Veteran's claim for service connection for hypothyroidism is being remanded for an addendum opinion.

The Board has remanded the case due to a duty to assist error and the need for a medical opinion regarding the etiology of the Veteran's thyroid condition, including hypothyroidism.

The Board has granted service connection for hypothyroidism, diabetes mellitus with diabetic retinopathy, and diabetic neuropathy of the lower extremities and right upper extremity. However, an earlier effective date is denied.

The Board denied the Veteran's claim for service connection of hypothyroidism, finding that there was no evidence to support a link between his current condition and his military service.

The Veteran's claims for service connection for hyperthyroidism, bilateral plantar fasciitis, right carpal tunnel syndrome, and left carpal tunnel syndrome are being remanded due to a duty to assist error. Additional medical opinions are needed to determine if these conditions are related to his military service.

The Veteran's hypothyroidism is rated at a 30 percent disability rating, effective from the date of the decision.

The Veteran's claim for service connection for hypothyroidism was granted with an effective date of June 18, 2016. This is due to the Veteran meeting the criteria as a Vietnam-era veteran who has been granted compensation for a covered herbicide disease (hypothyroidism) prior to January 1, 2021.

The Veteran's bladder cancer and hypothyroidism were not found to meet the criteria for a compensable initial rating during the relevant review period.